
GC38799
IRAK4-IN-4
Also known as 1-(7-methyl-2-phenylimidazo[1,2-a]pyridin-3-yl)-2-phenylethane-1,2-dione
IRAK4-IN-4 is an interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor extracted from patent CN107163044A, Compound15, has an IC50 of 2·8 nM
ChemicalCAS1850276-58-2MW340.37FormulaC22H16N2O2
- CAS number
- 1850276-58-2
- Molecular weight
- 340.37
- Formula
- C22H16N2O2
- Solubility
- DMSO: 25 mg/mL (73·45 mM)
- InChIKey
- AHNNWZOVCRQAAH-UHFFFAOYSA-N
- Catalogue number
- GC38799
- Brand
- GLPBIO
Computed properties PubChem CID 145712357 · XLogP 5.1 · TPSA 51.4 Ų · H-bond donors 0
- XLogP
- 5.1
- TPSA
- 51.4 Ų
- H-bond donors
- 0
- H-bond acceptors
- 3
- Rotatable bonds
- 4
- Heavy atoms
- 26
SMILES CC1=CC2=NC(=C(N2C=C1)C(=O)C(=O)C3=CC=CC=C3)C4=CC=CC=C4
Computed descriptors from PubChem (CID 145712357), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il